Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    EP02.04 - Early Stage Non-small Cell Lung Cancer - Systemic Therapy

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Early Stage Non-small Cell Lung Cancer - Systemic Therapy
    • +

      EP02.04-005 - Phase II NAUTIKA1 Study of Targeted Therapies in Stage II-III NSCLC: Preliminary Data of Neoadjuvant Alectinib for ALK+ NSCLC

      Presenter: JAY M LEE

      • Abstract

      Loading...

  • +

    EP05.01 - Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
    • +

      EP05.01-025 - Planned Interim Analysis of a Phase II Trial of Concurrent Durvalumab and Radiation Therapy for Locally Advanced Lung Cancer

      Presenter: Andreas Rimner

      • Abstract

      Loading...

  • +

    OA14 - New Techniques to Improve Outcome in Early Stage NSCLC Patients Treated with Surgery or Radiotherapy

    • 12:00 - 13:00
    • 8/09/2022
    • Location: Hall C8
    • Not for CME Credit
    • Type: Oral
    • Track: Early Stage Non-small Cell Lung Cancer
    • +

      OA14.06 - T-Cell Dynamics in Response to Neoadjuvant Atezolizumab in Early NSCLC by Antigen Response and T-Cell Receptor Sequencing

      12:22 - 12:32  |  Presenter: Filiz Oezkan

      • Abstract

      Loading...